bioRxivBioengineeringPreprint
A Long-lived Avatar for Modeling Age-Related Vascular Disease
Weifeng QiniD, Tu N Tran, Yiwei Xiao, Katelyn Ta, Ibrahem KandeliD, Ankit KumariD, Rashmi PandeyiD, Bao MA Dongchau, Vrutant V. ShahiD, Thi KC Nguyen, Kaylee N. CarteriD, Kristopher W. BrannaniD, Guangyu WangiD, Abhishek JainiD, Anahita MojiriiD, John P. CookeiD
Abstract
BackgroundCurrent microphysiological models do not support long-term investigations into the chronic effects of vascular risk factors and the development of vascular diseases. Prolonged culture frequently leads to cellular senescence and loss of functional integrity, resulting in variability and inconsistency in modeling chronic vascular responses. Here we aimed to develop and sustain a long-term multicellular human vascular avatar, addressing the critical need for long-term disease modeling and drug testing. MethodsTo identify the optimal media for longevity, cell identity and function were assessed by morphology, qPCR, beta-gal staining, ELISA, bulk RNA-seq and single cell RNA-seq analysis. After optimizing the culture media, iPSCs-derived ECs and VSMCs from unaffected and Hutchinson-Gilford Progeria Syndrome (HGPS) donors were grown in Gravitational Lumen Patterning (GLP) Vessel- Chips for 1-6 months to generate a long-lived vascular avatar for the study of vascular aging. ResultsGuided by quantitative morphological analyses and bulk RNAseq profiling, we generated a novel optimized culture media VSL (VEGF, SB431542 as a TGF-{beta} inhibitor, low fetal bovine serum) that enhances the long-term health of vascular endothelial cells (ECs). Furthermore, we modified the VSL formulation (mVSL) by modulating 8Br-cAMP, FGF, PDGF, and a cell viability enhancer HMH1015 levels to enhance EC-VSMC (vascular smooth muscle cell) crosstalk and support long-term cellular viability. Subsequently, we maintained and characterized a human vascular avatar with a three-dimensional extracellular matrix environment and 3D vascular architecture for over 180 days. Finally, we demonstrated that this long-lived human vascular avatar enabled modeling vascular aging using iPSC-derived vascular cells from patients with Hutchinson-Gilford Progeria Syndrome (HGPS). ConclusionsWe have successfully engineered and maintained a human vascular avatar for over 180 days. The vascular avatar provides a robust platform for modeling disease-associated vascular aging and for evaluating therapeutic strategies targeting chronic vascular disorders.
- organism: human
- assay: bulk RNA-seq
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bioengineered iPSC Vessels Recapitulate Human Vascular Physiological Function and Aging Phenotypes
Shun Itai, Reina Usami, … Takafumi Toyohara·bioRxiv·Sep 2, 2025
- Immortalized smooth muscle cells enhance in vitro vasculogenesis
Mohammad R. Nikmaneshi, Lennard M. Weide, … Lance L. Munn·AngiogenesisPeer-reviewed·Aug 20, 2026
- Progranulin deficiency aggravates aging-induced vascular injury
Renata de Azevedo Melo Luvizotto, André Ferreira do Nascimento, … Thiago B Bruder-Nascimento·bioRxiv·Nov 25, 2025
- An aged human heart tissue model showing age-related molecular and functional deterioration resembling the native heart
A. Acun, T. D. Nguyen, P. Zorlutuna·bioRxiv·Mar 22, 2018
- Engineering a Matrix-Preserving Vascular dECM Platform with Tunable Stiffness for In Vitro Vascular Remodeling
Yuna Heo, Rhonda Drewes, … Su‐Jin Heo·bioRxiv·May 13, 2026
- Artery-on-chip demonstrates smooth muscle function comparable to both healthy and diseased living tissues
Danielle Yarbrough, Roy Chen, … Sharon Gerecht·bioRxiv·Mar 6, 2025